1,650
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence rates of heathy stomach mucosa, chronic non-atrophic and atrophic gastritis in endoscopic biopsies in adults born in Finland in 1890–1977

Pages 874-881 | Received 14 Apr 2021, Accepted 06 May 2021, Published online: 30 May 2021

References

  • Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311–1315.
  • Schistosomes lf, Helicobacter p. IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241
  • Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. CMR. 2006;19(3):449–490.
  • Gisbert JP, Luna M, Gómez B, et al. Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Aliment Pharmacol Ther. 2006;23(6):713–719.
  • Siurala M. The story of gastritis. Scand J Gastoenterol. 1991;26(sup186):1–3.
  • Siurala M. Gastritis, its fate and sequelae. Ann Clin Res. 1981; 13:111–113.
  • Sipponen P, Maaroos H-I. Chronic gastritis. Scand J Gastroenterol. 2015;50(6):657–667.
  • Villako K, Maards H, Tammur R, et al. Helicobacter (Campylobacter) pylori infestation and the development and progression of chronic gastritis: results of long-term follow-up examinations of a random sample. Endoscopy. 1990;22(03):114–117.
  • Sipponen P, Kekki M, Siurala M. The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol. 1991;6(3):244–251.
  • Correa P. The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res. 1980;6:98–108.
  • Kekki M, Ihamäki T, Saukkonen M, et al. Progression of gastritis at a population level. Comparison of a long-term follow-up with stochastic analysis of cross-sectional data. Scand J Gastroenterol. 1980; 15:652–655.
  • Ihamauki T, Kekki M, Sipponen P, et al. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol. 1985;20(4):485–491.
  • Kuipers EJ, Uyterlinde AM, Peña AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995;345(8964):1525–1528.
  • Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM, et al. pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol. 1997;223:28–34.
  • Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010; 31:1104–1111.
  • Dixon MF. Histological responses to Helicobacter pylori infection: gastritis, atrophy and preneoplasia. Bailliers Clin Gastroenterol. 1995;9(3):467–486.
  • Takahashi S. Long-term Helicobacter pylori infection and the development of atrophic gastritis and gastric cancer in Japan. J Gastroenterol. 2002; 37(S13):24–27.
  • Samloff IM, Varis K, Ihamäki T, et al. Serum pepsinogens I and II and gastric acid output: effect of gastritis. Prog Clin Biol Res. 1985; 173:129–138.
  • Sipponen P, Valle J, Varis K, et al. Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol. 1990;25(5):513–519.
  • Sipponen P, Helske T, Järvinen P, et al. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut. 1994;35(9):1167–1171.
  • Sipponen P, Kosunen TU, Samloff IM, et al. Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen-year follow-up. Scand J Gastroenterol. 1996;31(3):229–232.
  • Lahner E, Bordi C, Cattaruzza MS, et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;22(5):471–481.
  • Hooi JKY, Lai W, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastrtoenterology. 2017;153(2):420–429.
  • Sipponen P. Helicobacter pylori: a cohort phenomenon. Am J Surg Pathol. 1995;19 (Suppl 1):S30–S6.
  • Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol. 1988;83:504–509.
  • Price AB. The sydney system: histological division. J Gastroenterol Hepatol. 1991;6(3):209–222.
  • Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161–1181.
  • Moayyedi P, Axon ATR, Feltbower R, et al. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol. 2002;31(3):624–631.
  • Zhang Y, Weck MN, Schöttker B, et al. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013;22(5):821–826.
  • Eidt S, Oberhuber G, Stolte M. Autoimmune gastritis in its various stages. Verh Dtsch Pathol. 1996; 80:196–198.
  • Varis O, Valle J, Siurala M. Is Helicobacter pylori involved in the pathogenesis of the gastritis characteristic of pernicious anaemia? Comparison between pernicious anaemia relatives and duodenal ulcer relatives. Scand J Gastroenterol. 1993;28(8):705–708.